Furthermore, we developed NDI, a peptide that blocks Notch1-DLL4 interaction, mitigating endothelial PANoptosis, inflammation, and ALI and significantly improving survival in a murine model of sepsis. This evidence concerns the gene DLL4 and Sepsis.